Elicio Therapeutics, Inc.ELTXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Deep AnalysisCompare

Elicio Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative cancer immunotherapies leveraging its proprietary amphiphile technology platform. Its pipeline includes targeted cancer vaccines and immunomodulatory candidates addressing both solid tumors and hematological malignancies, serving global oncology patient communities.